Cite
Irinotecan and temozolomide upfront and in relapsed Ewing sarcoma: A translational study on MGMT (O6-methylguanine–DNA methyltransferase) and ABCG2 (MGMTLiberati)
MLA
Anna Paioli, et al. “Irinotecan and Temozolomide Upfront and in Relapsed Ewing Sarcoma: A Translational Study on MGMT (O6-Methylguanine–DNA Methyltransferase) and ABCG2 (MGMTLiberati).” Journal of Clinical Oncology, vol. 38, May 2020, p. e23564. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....84d7274810c6f7e0ac1e3b6f6a775eec&authtype=sso&custid=ns315887.
APA
Anna Paioli, Alessandro Parra, Alberto Righi, Luca Morandi, Stefano Ferrari, Elisabetta Setola, Lorenzo D’Ambrosio, Giovanni Grignani, Rossella Hakim, Massimo Eraldo Abate, Franca Fagioli, Marilena Cesari, Katia Scotlandi, Asaftei Dorin Sebastian, Davide Maria Donati, Alessandra Longhi, Michela Pasello, Maria Cristina Manara, Robin L. Jones, & Emanuela Palmerini. (2020). Irinotecan and temozolomide upfront and in relapsed Ewing sarcoma: A translational study on MGMT (O6-methylguanine–DNA methyltransferase) and ABCG2 (MGMTLiberati). Journal of Clinical Oncology, 38, e23564.
Chicago
Anna Paioli, Alessandro Parra, Alberto Righi, Luca Morandi, Stefano Ferrari, Elisabetta Setola, Lorenzo D’Ambrosio, et al. 2020. “Irinotecan and Temozolomide Upfront and in Relapsed Ewing Sarcoma: A Translational Study on MGMT (O6-Methylguanine–DNA Methyltransferase) and ABCG2 (MGMTLiberati).” Journal of Clinical Oncology 38 (May): e23564. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....84d7274810c6f7e0ac1e3b6f6a775eec&authtype=sso&custid=ns315887.